ALOX15B
Basic information
Region (hg38): 17:8039034-8049134
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALOX15B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 50 | 56 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 50 | 6 | 1 |
Variants in ALOX15B
This is a list of pathogenic ClinVar variants found in the ALOX15B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-8039252-A-T | not specified | Uncertain significance (Jan 18, 2022) | ||
17-8039264-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
17-8039274-A-G | not specified | Uncertain significance (Jan 29, 2024) | ||
17-8039450-A-T | not specified | Uncertain significance (Jan 10, 2023) | ||
17-8039476-G-C | not specified | Uncertain significance (Feb 16, 2023) | ||
17-8039489-C-G | not specified | Uncertain significance (Aug 17, 2021) | ||
17-8039506-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
17-8039530-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
17-8039550-C-A | not specified | Uncertain significance (Jun 16, 2023) | ||
17-8039551-C-A | not specified | Uncertain significance (Jan 10, 2023) | ||
17-8039931-G-A | not specified | Uncertain significance (May 09, 2023) | ||
17-8039957-G-C | not specified | Uncertain significance (Nov 15, 2021) | ||
17-8042407-A-G | Likely benign (Jul 31, 2018) | |||
17-8042408-T-A | not specified | Uncertain significance (Jul 09, 2024) | ||
17-8042421-G-A | not specified | Likely benign (May 05, 2023) | ||
17-8042425-A-G | not specified | Uncertain significance (May 30, 2023) | ||
17-8042490-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
17-8042830-A-G | not specified | Uncertain significance (Apr 13, 2022) | ||
17-8042861-A-C | not specified | Uncertain significance (Nov 18, 2022) | ||
17-8044834-G-A | not specified | Likely benign (Sep 19, 2022) | ||
17-8044880-T-C | not specified | Uncertain significance (Sep 08, 2024) | ||
17-8044921-C-T | Likely benign (Dec 31, 2019) | |||
17-8044935-C-A | not specified | Uncertain significance (Apr 18, 2023) | ||
17-8044935-C-G | not specified | Uncertain significance (Jan 09, 2024) | ||
17-8044939-G-T | not specified | Uncertain significance (Feb 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALOX15B | protein_coding | protein_coding | ENST00000380183 | 14 | 10118 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.48e-18 | 0.0213 | 125389 | 0 | 359 | 125748 | 0.00143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.272 | 383 | 398 | 0.962 | 0.0000228 | 4349 |
Missense in Polyphen | 165 | 160.53 | 1.0278 | 1849 | ||
Synonymous | 1.42 | 145 | 168 | 0.861 | 0.00000968 | 1377 |
Loss of Function | 0.689 | 30 | 34.4 | 0.873 | 0.00000175 | 350 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00419 | 0.00412 |
Ashkenazi Jewish | 0.00189 | 0.00189 |
East Asian | 0.00141 | 0.00141 |
Finnish | 0.00103 | 0.00102 |
European (Non-Finnish) | 0.00151 | 0.00150 |
Middle Eastern | 0.00141 | 0.00141 |
South Asian | 0.000563 | 0.000555 |
Other | 0.00213 | 0.00212 |
dbNSFP
Source:
- Function
- FUNCTION: Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. Converts arachidonic acid to 15S- hydroperoxyeicosatetraenoic acid/(15S)-HPETE. Also acts on linoleic acid to produce 13-hydroxyoctadecadienoic acid/13-HPODE. Has no detectable 8S-lipoxygenase activity but reacts with (8S)- HPETE to produce (8S,15S)-diHPETE. May regulate progression through the cell cycle and cell proliferation. May also regulate cytokine secretion by macrophages and therefore play a role in the immune response. May also regulate macrophage differentiation into proatherogenic foam cells. {ECO:0000269|PubMed:10625675, ECO:0000269|PubMed:11839751, ECO:0000269|PubMed:12704195, ECO:0000269|PubMed:16112079, ECO:0000269|PubMed:18067895, ECO:0000269|PubMed:22912809, ECO:0000269|PubMed:24497644}.;
- Pathway
- Serotonergic synapse - Homo sapiens (human);Arachidonic acid metabolism - Homo sapiens (human);Etodolac Action Pathway;Ketoprofen Action Pathway;Ibuprofen Action Pathway;Rofecoxib Action Pathway;Acetylsalicylic Acid Action Pathway;Diflunisal Action Pathway;Leukotriene C4 Synthesis Deficiency;Acetaminophen Action Pathway;Celecoxib Action Pathway;Sulindac Action Pathway;Diclofenac Action Pathway;Ketorolac Action Pathway;Naproxen Action Pathway;Etoricoxib Action Pathway;Carprofen Action Pathway;Flurbiprofen Action Pathway;Fenoprofen Action Pathway;Antrafenine Action Pathway;Antipyrine Action Pathway;Lumiracoxib Action Pathway;Magnesium salicylate Action Pathway;Trisalicylate-choline Action Pathway;Nepafenac Action Pathway;Phenylbutazone Action Pathway;Lornoxicam Action Pathway;Salsalate Action Pathway;Tenoxicam Action Pathway;Tiaprofenic Acid Action Pathway;Tolmetin Action Pathway;Salicylic Acid Action Pathway;Salicylate-sodium Action Pathway;Oxaprozin Action Pathway;Valdecoxib Action Pathway;Nabumetone Action Pathway;Indomethacin Action Pathway;Meloxicam Action Pathway;Suprofen Action Pathway;Bromfenac Action Pathway;Mefenamic Acid Action Pathway;Arachidonic Acid Metabolism;Piroxicam Action Pathway;Selenium Micronutrient Network;Eicosanoid Synthesis;nfat and hypertrophy of the heart ;Metabolism of lipids;Prostaglandin Leukotriene metabolism;Synthesis of 15-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Metabolism;Fatty acid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.0984
- rvis_EVS
- 0.98
- rvis_percentile_EVS
- 90.46
Haploinsufficiency Scores
- pHI
- 0.116
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.397
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.706
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Alox8
- Phenotype
Gene ontology
- Biological process
- lipid metabolic process;apoptotic process;negative regulation of cell population proliferation;positive regulation of macrophage derived foam cell differentiation;arachidonic acid metabolic process;lipoxygenase pathway;negative regulation of cell migration;prostate gland development;regulation of epithelial cell differentiation;positive regulation of peroxisome proliferator activated receptor signaling pathway;linoleic acid metabolic process;positive regulation of keratinocyte differentiation;negative regulation of cell cycle;negative regulation of growth;hepoxilin biosynthetic process;oxidation-reduction process;positive regulation of chemokine secretion
- Cellular component
- nucleus;cytosol;cytoskeleton;plasma membrane;membrane;extrinsic component of membrane;extracellular exosome
- Molecular function
- iron ion binding;calcium ion binding;lipid binding;linoleate 13S-lipoxygenase activity;arachidonate 8(S)-lipoxygenase activity;arachidonate 15-lipoxygenase activity